海南海药
(000566)
| 流通市值：39.51亿 | | | 总市值：43.98亿 |
| 流通股本：11.65亿 | | | 总股本：12.97亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,252,651,828.58 | 959,574,571.06 | 495,029,847.71 | 1,779,052,193.18 |
| 营业收入 | 1,252,651,828.58 | 959,574,571.06 | 495,029,847.71 | 1,779,052,193.18 |
| 二、营业总成本 | 1,372,235,051.41 | 1,022,000,876.7 | 510,948,487.72 | 1,969,736,475.02 |
| 营业成本 | 793,862,588.68 | 593,489,713.98 | 300,760,043.28 | 1,010,823,776.2 |
| 税金及附加 | 13,571,107.82 | 11,177,654.04 | 5,879,929.77 | 21,636,577.81 |
| 销售费用 | 299,310,245.19 | 240,426,092.45 | 110,469,162.46 | 522,911,940.19 |
| 管理费用 | 124,239,253.79 | 79,974,099.86 | 43,069,517.59 | 197,957,104.43 |
| 研发费用 | 41,705,221.62 | 29,407,927.85 | 15,386,422.96 | 49,153,807.86 |
| 财务费用 | 99,546,634.31 | 67,525,388.52 | 35,383,411.66 | 167,253,268.53 |
| 其中:利息费用 | 125,718,905.88 | 85,401,408.32 | 44,112,849.97 | 218,195,842.7 |
| 其中:利息收入 | 25,876,494.26 | 17,606,888.98 | 9,234,275.36 | 49,435,729.19 |
| 加:公允价值变动收益 | 2,183,730.56 | 2,286,813.25 | 3,798,473.62 | -57,760,523.17 |
| 加:投资收益 | -4,952,076.21 | -12,375,570.22 | 5,290,698.04 | 254,986,630.03 |
| 资产处置收益 | -3,382.97 | -3,382.97 | -272.65 | 19,352,800.82 |
| 资产减值损失(新) | 899,189.63 | 914,206.55 | -2,564.66 | -1,810,562.5 |
| 信用减值损失(新) | 68,681,199.06 | 69,555,422.22 | 5,460,453.65 | -107,855,853.09 |
| 其他收益 | 15,308,269.76 | 7,780,799.86 | 6,139,137.92 | 22,287,000.48 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -37,466,293 | 5,731,983.05 | 4,767,285.91 | -61,484,789.27 |
| 加:营业外收入 | 631,108.29 | 297,081.75 | 31,700.88 | 4,417,951.78 |
| 减:营业外支出 | 222,541.08 | 202,891.43 | 72,349.44 | 1,829,509.91 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -37,057,725.79 | 5,826,173.37 | 4,726,637.35 | -58,896,347.4 |
| 减:所得税费用 | 2,331,094.65 | 4,028,072.64 | 4,203,415.33 | -61,273,398.39 |
| 六、净利润 | -39,388,820.44 | 1,798,100.73 | 523,222.02 | 2,377,050.99 |
| 持续经营净利润 | -39,388,820.44 | 1,798,100.73 | 523,222.02 | -310,328,904.86 |
| 终止经营净利润 | - | - | - | 312,705,955.85 |
| 归属于母公司股东的净利润 | -24,546,290.84 | 9,546,078.21 | 4,669,720.32 | 10,515,675.29 |
| 少数股东损益 | -14,842,529.6 | -7,747,977.48 | -4,146,498.3 | -8,138,624.3 |
| (一)基本每股收益 | -0.02 | 0.01 | 0 | 0.01 |
| (二)稀释每股收益 | -0.02 | 0.01 | 0 | 0.01 |
| 八、其他综合收益 | 1,341,835.36 | 1,984,154.06 | -1,208,392.82 | 5,048,427.75 |
| 归属于母公司股东的其他综合收益 | 1,341,835.36 | 1,984,154.06 | -1,208,392.82 | 5,048,427.75 |
| 九、综合收益总额 | -38,046,985.08 | 3,782,254.79 | -685,170.8 | 7,425,478.74 |
| 归属于母公司股东的综合收益总额 | -23,204,455.48 | 11,530,232.27 | 3,461,327.5 | 15,564,103.04 |
| 归属于少数股东的综合收益总额 | -14,842,529.6 | -7,747,977.48 | -4,146,498.3 | -8,138,624.3 |
| 公告日期 | 2023-10-28 | 2023-08-29 | 2023-04-27 | 2023-04-11 |
| 审计意见(境内) | | | | 标准无保留意见 |